ConductScience.org, home

Gene · 57721

NIH grants1,078

NIH grants whose papers are about the gene, through NIH's grant-paper links.

81 to 100 of 1,078

Download this page as JSON
GrantTitleMETTL14 papersNewest fiscal year
R01HL157539Role of the TET1 short isoform in MDS development and maintenance22025
R01NS124668Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas22025
R03CA287274Profiling Epitranscriptomic RNA editing in Pediatric Cancer22025
R21AI181742SAMHD1-mediated regulation of innate immunity during SARS-CoV-2 infection22025
R33AI169659Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development22025
R35CA197628Metabolic gatekeepers in B-cell malignancies22025
R35CA232115Role of the Epitranscriptome in Cancer22025
R35GM131858Interrogating Complex Methylome Network with Integrated Chemical Biology Tools22025
R37CA230617Hormone signaling and translation control in advanced prostate cancer22025
R37CA233691Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia22025
RC2DK139552Epitranscriptomics in human obesity and type 2 diabetes22025
T32AI007647Training Program in Mechanisms of Virus-Host Interactions22025
T32CA009594Multi-Disciplinary Training Grant in Cancer Research22025
T32CA121938UCSD Cancer Center Training Program in Drug Development22025
T32ES011564UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM22025
U54MD007601Ola HAWAII22025
ZIAHG200338Molecular Analyses of Endometrial Cancer22025
I01BX002665Mechanisms of Resistance to mTOR Targeted Therapies12025
OT2OD032581AIM-AHEAD Coordinating Center - All Four Cores12025
P01CA013106Targeting Transcription and Splicing in Cancer12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/57721/grants?page=5